© 2026 Nanjing Finechem Holdings Co., Ltd,
All Right Reserved
Rapamycin, commonly known in the scientific community as Sirolimus, belongs to the class of macrolide compounds. The formula stands as C51H79NO13, pointing to a structure packed with carbon, hydrogen, nitrogen, and oxygen atoms. Stemming from the bacterium Streptomyces hygroscopicus, the molecule gained attention for its immunosuppressive effects, but its complex, ring-based structure can also be recognized by those working in organic synthesis. Various industries recognize Rapamycin’s immense biological science value, yet that value relies on understanding this raw material at the physical and chemical level before considering broader uses.
Rapamycin typically appears as a white to off-white, crystalline powder. Laboratory workers who prepare Rapamycin for experiments notice the fine, brittle flakes that break apart readily, a crucial factor when measuring exact amounts for dilution or analysis. The pure compound remains solid at room temperature and carries a slight musty odor. Its melting point rests around 183-185°C, indicating solid chemical stability under standard transportation and storage conditions. Molecular mass reaches approximately 914.2 g/mol—large compared to standard pharmaceuticals—reflecting the complexity of the molecule’s structure. The density hovers around 1.2 g/cm³. Whether obtained as fine powder, larger flakes, or crystals, Rapamycin demands gentle handling; it clumps with humidity or static, highlighting the importance of controlled environments during distribution and storage.
The molecule’s structure shows multiple rings—macrolactone being the core—and several side chains with various chemical groups, such as keto, hydroxyl, and methoxy side chains. Chemists recognize this motif in antibiotics and immunosuppressants, but Rapamycin’s particular configuration brings unique interactions in biological systems. Rapamycin dissolves in organic solvents like ethanol and chloroform, yet resists dissolution in water, making direct mixing challenging. This lack of water solubility pushes researchers to use co-solvents or surfactants during preparations for lab or commercial applications. Material form—whether solid powder, crystalline flakes, or pearl-like granules—links directly to source and purification route. Bulk distribution typically favors powders or pellets for easier division and weighing.
United Nations trade and customs rules identify Rapamycin by the HS Code 293499. The specification sheet for Rapamycin details purity levels, expected particle size, residual solvent content, and permissible moisture percentage—each facet vital for pharmaceutical or research quality control. Typical purity requirements exceed 98%. Laboratories test for residual solvents because Rapamycin’s solubility in organic compounds makes it prone to traces. Specifications cover visible characteristics, molecular weight, and physical form—each checked for consistency before shipment or use. Custom synthesis labs report bulk density for powder forms, influencing packing and storage guidelines. The HS code not only supports import/export trading but also signals regulators to apply safety standards for handling, labeling, and customs clearance.
Working with Rapamycin means thinking about more than just chemical data. As a strong immunosuppressant, exposure—even unintentional—carries health risks, especially in powder form, where inhalation or skin contact can occur. Labels warn users about harmful effects on health if mishandled. Gloves, masks, and specific ventilation setups become necessary in any facility where Rapamycin is weighed or dissolved. MSDS documentation reports hazards including respiratory irritation, allergic reactions, and risks from chronically low exposure. Disposing of Rapamycin requires incineration or chemical neutralization, since careless disposal could harm water systems or soil. Workplaces handling Rapamycin invest in chemical-resistant gear and thorough safety audits, prioritizing the welfare of workers above speed or cost cuts.
Handling challenges spark innovation. Many research labs shift from raw powder to pre-dissolved Rapamycin solutions, reducing dust and exposure. Polymeric coatings or encapsulated granules help manage volatility and shelf life. Automation steps in during large-scale manufacturing to reduce operator exposure, with robotic arms managing container transfers and precise weighing. Closed-system dissolution set-ups cut down on airborne particles, while air filtration systems and humidity controls create safer environments. Some facilities provide on-site training focused on chemical hygiene and emergency response for everyone handling Rapamycin. Industry advocacy for clear labeling, traceable logistics, and harmonized specifications helps minimize supply chain confusion and supports consistent, safe usage at every step.
Pharmaceutical manufacturers demand reliable, specification-controlled Rapamycin both as a standalone agent and as a starting point for chemical modifications. The solid-state consistency and care in packaging give formulators control over blending, tablet compression, and encapsulation. Research institutions value bulk Rapamycin for preclinical animal studies or cell culture work, and attention to low moisture or precise particle sizing links directly to reproducibility. Although the molecule’s primary use appears in immunosuppression, bioscience sectors explore new roles spanning cancer research and age-related investigations. The robust chemical framework supports derivative synthesis and builds out portfolios that define the future of molecular medicine.
